An update on novel therapies for treating patients with arterial thrombosis

US Tantry, S Duhan, E Navarese… - Expert Review of …, 2023 - Taylor & Francis
Introduction Antithrombotic therapy field is undergoing rapid and significant changes during
the past decade. In addition to new therapeutic strategies with existing targets, investigators …

Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point–Blinded, Noninferiority …

H Wu, L Xu, X Zhao, H Zhang, K Cheng, X Wang… - Circulation, 2023 - Am Heart Assoc
Background: Dual antiplatelet therapy (DAPT) with aspirin as a background therapy has
become the standard care after percutaneous coronary intervention. However, some …

[HTML][HTML] Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making

C Laferrière, C Moazzami, E Belley-Côté, KR Bainey… - CJC open, 2023 - Elsevier
Background Since the publication of the 2010 Canadian antiplatelet guidelines, there have
been several large randomized controlled trials (RCTs) evaluating the role of aspirin (ASA) …

[PDF][PDF] A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage

T Li, N Ding, H Guo, R Hua, Z Lin, H Tian, Y Yu… - Cell Host & Microbe, 2024 - cell.com
Aspirin-related gastrointestinal damage is of growing concern. Aspirin use modulates the gut
microbiota and associated metabolites, such as bile acids (BAs), but how this impacts …

Long-Term P2Y12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention

D Capodanno, DJ Angiolillo - Circulation, 2023 - Am Heart Assoc
In patients with coronary artery disease and prior myocardial revascularization, long-term
use of low-dose aspirin is recommended with high grade and level of evidence by clinical …